H. Res. 387 is a simple House resolution that recognizes May 2025 as “National Asthma and Allergy Awareness Month” and urges the American people to observe the month with appropriate ceremonies and activities.
The text compiles recent prevalence, healthcare utilization, economic, and mortality figures and highlights racial and ethnic disparities in asthma and the rising incidence of food allergy in children.
The resolution is purely declarative: it signals congressional attention and creates a congressional finding record that advocates and agencies can cite, but it does not appropriate funds, create new programs, or impose regulatory obligations. Its practical value lies in coordinating public messaging and providing a legislative hook for awareness campaigns and grant proposals.
At a Glance
What It Does
The bill adopts a congressional finding package on the prevalence, cost, and consequences of asthma and food allergies and designates May 2025 as a month for public observance. It ‘‘calls upon the American people to observe such month with appropriate ceremonies and activities.’
Who It Affects
Primary practical audiences are public-health actors—federal, state, and local health departments—patient-advocacy groups, health-care providers, schools, and employers that run outreach or education programs. The resolution does not create legal duties for these entities.
Why It Matters
As a symbolic act, the resolution consolidates specific data points and demographic findings into the congressional record, which advocates and agencies commonly use to justify coordinated outreach, fundraising, and targeted programs. Because it neither authorizes spending nor changes law, its influence will be through messaging and agenda-setting rather than direct programmatic impact.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
H. Res. 387 is a short, two-part document: a set of ‘‘whereas’’ clauses that lay out the public-health problem and a single resolved clause that names May 2025 as an observance month and invites public participation.
The ‘‘whereas’’ statements assemble a string of statistics—on prevalence, missed school and work days, emergency visits, economic cost, mortality, and racial disparities—to make the case that asthma and allergic disease are public-health priorities that merit focused attention.
Because the resolution is declaratory, the only legal action it takes is recognition; it does not change federal programs, create entitlements, or direct agencies to expend resources. In practice, similar observance resolutions serve as timing devices: they encourage federal and state agencies, nonprofit groups, professional societies, schools, and employers to schedule outreach, training, and awareness events in the named month, and they give advocates a congressional citation when applying for grants or seeking media coverage.The bill also names specific population concerns—higher burdens among Black, Hispanic, and Indigenous communities and rising food-allergy rates among children—which can help target messaging.
That targeting is advisory: the resolution signals priorities without allocating funds or requiring measurement, so follow-through depends on third-party actors deciding to convert the recognition into programs or services.
The Five Things You Need to Know
The resolution designates May 2025 as “National Asthma and Allergy Awareness Month.”, It is a nonbinding House resolution that calls on the American people to observe the month with “appropriate ceremonies and activities” but does not authorize spending or create programs.
The preamble assembles detailed findings: the bill cites roughly 4.9 million U.S. children and nearly 28 million people overall with asthma, 1.5 million annual emergency-department visits for asthma, and over 3,500 asthma deaths in 2021.
The bill highlights economic and social impacts, referencing about 7.9 million school days and 10.9 million work days lost (2018 averages) and an $81.9 billion annual cost figure for the 2008–2013 period.
The text calls out disparities and changing incidence: it states that Black, Hispanic, and Indigenous people face the highest asthma burden and that food allergies have increased among children—particularly Black children—naming roughly 20.3 million Americans with food allergies, including about 4.3 million children.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Congressional findings assembling prevalence, burden, cost, and disparities
The ‘‘whereas’’ clauses collect epidemiological and economic data—prevalence by age, school- and work-day losses, emergency visits, hospitalization drivers, mortality, overall cost estimates, and food-allergy counts—and explicitly identify Black, Hispanic, and Indigenous populations as carrying the highest asthma burden. Practically, those findings do two things: they create a documented rationale that advocates and agencies can cite when requesting resources or planning outreach, and they frame the problem in demographic terms that can justify targeted communications.
Designation and call to observe
The core operative sentence recognizes May 2025 as the awareness month and ‘‘calls upon the American people to observe such month with appropriate ceremonies and activities.’’ That language is intentionally broad—covering everything from school lessons to public-service campaigns—but it imposes no legal requirements. The clause is a timing and symbolic tool intended to spur voluntary activity rather than mandate federal action.
Declaratory nature and absence of appropriation
There is no appropriation, regulatory instruction, or creation of programmatic authority in the text. The resolution is a formal expression of the House’s position; it does not change agency authorities or funding levels. Its leverage will depend on whether federal and state public-health actors, nonprofits, and private-sector partners use the designation as an organizing point for already-budgeted activities or informal partnerships.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- People with asthma and food allergies: the designation increases visibility of their conditions, which can expand outreach, education, and potentially improve access to existing resources through heightened public attention.
- Patient-advocacy organizations and professional societies: they gain a congressional citation to coordinate campaigns, raise funds, and press for follow-on policy or programmatic changes.
- Schools and employers running health education: the observance provides a ready-made calendar anchor for training, inhaler-plan distribution, and accommodations messaging without needing to develop standalone justification.
- State and local health departments: the resolution offers a public-health framing they can use to schedule outreach and to leverage partnerships during May.
- Media and public-health communicators: the month creates a news peg to raise awareness, highlight disparities, and push for preventive measures.
Who Bears the Cost
- Federal, state, and local public-health agencies (soft costs): agencies may face unfunded expectations to produce guidance, campaigns, or data summaries timed to May without additional appropriations.
- Nonprofit organizations and advocacy groups: converting the observance into events or campaigns will likely require staff time and fundraising; smaller groups may absorb disproportionate resource strain.
- Schools and local districts: if communities expect school-based events or training, local education budgets and staff time may be used without new funding.
- Health-care providers and clinics: increased outreach can lead to higher demand for asthma action plans and allergy services, producing schedule and billing impacts that providers must absorb or bill for.
- Employers running workplace activities: voluntary observances may impose administrative and time costs for employers coordinating awareness sessions or accommodations.
Key Issues
The Core Tension
The bill balances visibility against capacity: it amplifies the public-health importance of asthma and allergies and names demographic disparities, but does so without creating funding, mandates, or accountability—leaving advocates and agencies to turn symbolic recognition into substantive change with existing, often limited, resources.
The central implementation tension is that a public-awareness designation raises expectations without providing resources or metrics. The resolution aggregates data to justify attention, but it contains no mechanism to measure whether awareness activities reduce missed school or work days, emergency visits, or mortality.
That gap leaves open whether the designation becomes a useful coordination tool or an empty symbolic gesture.
Operationally, language like ‘‘calls upon the American people’’ and ‘‘appropriate ceremonies and activities’’ is vague. It maximizes flexibility but produces ambiguity about who should act, what constitutes a meaningful activity, and how to prioritize outreach for the populations the bill explicitly names.
The findings reference dated economic figures (2008–2013) alongside recent mortality data, which mixes timeframes and may complicate efforts to use the resolution as an evidence base for funding decisions. Finally, acknowledging racial and ethnic disparities without assigning responsibility or resources risks raising expectations from communities that are least resourced to respond.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.